MRSN icon

Mersana Therapeutics

120 hedge funds and large institutions have $230M invested in Mersana Therapeutics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.5M
Puts
$1.26M
Net Calls
Net Calls Change

Top Buyers

1 +$11.4M
2 +$3.96M
3 +$1.15M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.13M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.1M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$354K
52
$353K
53
$321K
54
$302K
55
$279K
56
$248K
57
$244K
58
$221K
59
$219K
60
$215K
61
$200K
62
$189K
63
$168K
64
$162K
65
$143K
66
$132K
67
$126K
68
$123K
69
$116K
70
$114K
71
$102K
72
$101K
73
$95K
74
$94K
75
$93.4K